Società Mallinckrodt plc

MNK

IE000O3L0NQ3

Dirigenti

Amministratori

Classe di azioni

Azionisti

Partecipazioni

Coordinate società

Società del gruppo

Settore

Settore Prodotti farmaceutici - Altri

Strumento inattivo

Mallinckrodt plc sviluppa, produce, commercializza e distribuisce prodotti farmaceutici e terapie di marca e generici. L'azienda opera in due segmenti riferibili: Marchi speciali e Generici speciali. Il segmento Specialty Brands comprende marchi farmaceutici speciali. Il segmento Specialty Generics comprende farmaci generici speciali di nicchia e ingredienti farmaceutici attivi. Il segmento Specialty Generics si concentra sulla fornitura ai clienti di farmaci generici speciali e di ingredienti farmaceutici attivi (API). L'Azienda si concentra su diverse aree terapeutiche, come le malattie autoimmuni e rare in settori specialistici quali neurologia, reumatologia, epatologia, nefrologia, pneumologia, oftalmologia e oncologia; immunoterapia e terapie respiratorie critiche neonatali; analgesici, sostituti cutanei coltivati e prodotti gastrointestinali. Il suo portafoglio prodotti comprende Acthar Gel, INOmax, Therakos photopheresis, StrataGraft, Terlivaz e Amitiza.

Numero di dipendenti: 2 786

Dirigenti	Titolo	Età	Da
Sigurdur Olafsson CEO	Chief Executive Officer	55	25/06/22
Bryan Reasons DFI	Director of Finance/CFO	56	18/03/19
Kassie Harrold CMP	Compliance Officer	45	-
Peter Richardson CTO	Chief Tech/Sci/R&D Officer	64	12/01/23
Derek Belz IRO	Public Communications Contact	-	01/04/22
Daniel J. Speciale IRC	Investor Relations Contact	-	01/01/13
Lisa French PRN	Corporate Officer/Principal	55	-
Jason Goodson PRN	Corporate Officer/Principal	43	-
Mark Tyndall LAW	General Counsel	48	01/06/14
Stephen Andrew Welch PRN	Corporate Officer/Principal	47	-

Amministratori	Titolo	Età	Da
Wesley Wheeler BRD	Director/Board Member	68	02/02
Paul Bisaro CHM	Chairman	63	16/06/22
Sigurdur Olafsson CEO	Chief Executive Officer	55	25/06/22
David Stetson BRD	Director/Board Member	67	14/11
Shah Hussain BRD	Director/Board Member	59	02/02
Katina Dorton BRD	Director/Board Member	66	02/02
Jon Zinman BRD	Director/Board Member	44	14/11

	Voto	Quantità	Flottante	Autocontrollo	Flottante totale
Azione A	1	19 696 335	19 676 335 ( 99,90 %)	0	99,90 %

Nome	Azioni	%	Valorizzazione
GoldenTree Asset Management LP 16,72 %	3 294 035	16,72 %	33 $
Hein Park Capital Management LP 9,086 %	1 789 673	9,086 %	18 $
Steven Tananbaum 0,1015 %	20 000	0,1015 %	0 $

Nome	Azioni	%	Valorizzazione
SILENCE THERAPEUTICS PLC 4.70%	5 063 859	4.70%	4 456 196 $

Mallinckrodt Plc

College Business & Technology Park Cruiserath

15, Blanchardstown

+353 1 696 0000

http://mallinckrodt.com

Nome	Categoria e settore
Sucampo Pharma LLC Sucampo Pharma LLC Miscellaneous Commercial ServicesCommercial Services Sucampo Pharma LLC engages in the pharmaceutical product development. It develops the naturally occurring compound prostones, including lubiprostone under the brand Amitiza, which is used for the treatment of chronic constipation, chronic idiopathic constipation (CIC) in adults, and irritable bowel syndrome with constipation (IBS-C). The company is headquartered in Osaka, Japan.	Miscellaneous Commercial Services
Sucampo GmbH Sucampo GmbH Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Sucampo GmbH is a Swiss company that manufactures and distributes pharmaceuticals and health care products. The company is based in Zug, Switzerland. The company was founded by Ryuji Ueno, Sachiko Kuno. Sucampo was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on December 29, 2010 for $120 million.	Pharmaceuticals: Major
Mallinckrodt Group SARL
Mallinckrodt Windsor SARL Mallinckrodt Windsor SARL Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Windsor SARL provides pharmaceutical products. The company is based in Luxembourg, Luxembourg.	Pharmaceuticals: Major
Cache Holdings Ltd. Cache Holdings Ltd. Financial ConglomeratesFinance Part of Mallinckrodt Plc, Cache Holdings Ltd. is an investment holding Bermudian company. The company is based in Hamilton, Bermuda.	Financial Conglomerates
Mallinckrodt International Holdings SARL Mallinckrodt International Holdings SARL Financial ConglomeratesFinance Part of Mallinckrodt Plc, Mallinckrodt International Holdings SARL functions as an investment holding Luxembourger company. The company is based in Luxembourg, Luxembourg.	Financial Conglomerates
Mallinckrodt Pharmaceuticals Ltd. Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Mallinckrodt Plc, Mallinckrodt Pharmaceuticals Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in Staines Upon Thames, UK and was founded in 2015.	Pharmaceuticals: Major

Biotecnologia/Farmaceutici

Biotecnologia/Farmaceutici

Prodotti farmaceutici

Prodotti farmaceutici - Altri

	Variaz. 1 gen.	Capi.
ELI LILLY AND COMPANY	+54,07%	809 Mrd
NOVO NORDISK A/S	+39,24%	621 Mrd
JOHNSON & JOHNSON	-7,05%	351 Mrd
MERCK & CO., INC.	+15,44%	319 Mrd
ABBVIE INC.	+5,72%	289 Mrd
ASTRAZENECA PLC	+14,75%	238 Mrd
ROCHE HOLDING AG	-0,61%	221 Mrd
NOVARTIS AG	+14,52%	218 Mrd
AMGEN INC.	+7,42%	166 Mrd

Prodotti farmaceutici - Altri